Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit

Genomics

Volumn 74, Issue 3, 2001, Pages 320-332

  Berti, Lucia ^a   Mittler, Gerhard ^a   Przemeck, Gerhard K H ^b   Stelzer, Gertraud ^a   Günzler, Barbara ^a   Amati, Francesca ^c   Conti, Emanuela ^d   Dallapiccola, Bruno ^d   Hrabé de Angelis, Martin ^b   Novelli, Giuseppe ^c   Meisterernst, Michael ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SUBUNIT;

AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 22Q; CHROMOSOME MAP; CONTROLLED STUDY; DIGEORGE SYNDROME; EMBRYO; GENE DELETION; GENE ISOLATION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; IN SITU HYBRIDIZATION; MORPHOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VELOCARDIOFACIAL SYNDROME;

EID: 0035874878     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2001.6566     Document Type: Article

References (58)

1. A novel glutamine-rich putative transcriptional adaptor protein (TIG-1), preferentially expressed in placental and bone-marrow tissues
2. Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome
3. Isolation of a zinc finger gene consistently deleted in DiGeorge syndrome
4. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein
5. Chromosome mapping of the human arrestin (SAG), beta-arrestin 2 (ARRB2), and beta-adrenergic receptor kinase 2 (ADRBK2) genes
6. Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development
7. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Upper limb malformations in DiGeorge syndrome
10. A genetic etiology for DiGeorge syndrome: Consistent deletions and microdeletions of 22q11
11. The DNA sequence of human chromosome 22
12. A mediator required for activation of RNA polymerase II transcription in vitro
13. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation
14. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease
15. Gene expression: Increasing evidence for a transcriptosome
16. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11
17. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators
18. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1
19. Fate of the mammalian cardiac neural crest
20. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways
21. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II
22. Role of neural crest in congenital heart disease
23. Neural crest and cardiovascular patterning
24. An RNA polymerase II holoenzyme responsive to activators
25. RNA polymerase II cofactor PC2 facilitates activation of transcription by GAL4-AH in vitro
26. Congenital heart disease in mice deficient for the DiGeorge syndrome region
27. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice
28. The USA-derived transcriptional coactivator PC2 is a submodule of TRAP/SMCC and acts synergistically with other PCs
29. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells
30. Genetics of limb anomalies in humans
31. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line
32. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR)
33. Activation of class II gene transcription by regulatory factors is potentiated by a novel activity
34. TBX1 is responsible for cardiovascular defects in velocardio-facial/DiGeorge syndrome
35. Composite co-activator ARC mediates chromatin-directed transcriptional activation
36. Diagnosis of DiGeorge and Williams syndromes using FISH analysis of peripheral blood smears
37. Detection of an atypical 22q11 deletion that has no overlap with the DiGeorge syndrome critical region
38. Isolation of nuclear extracts from fragile cells: A simplified procedure applied to thymocytes
39. RNA polymerase II elongation through chromatin
40. Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome
41. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome
42. Limb anomalies in DiGeorge and CHARGE syndromes
43. Transcriptional activation by recruitment
44. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
45. ZNF74, a gene deleted in DiGeorge syndrome, is expressed in human neural crest-derived tissues and foregut endoderm epithelia
46. The role of general initiation factors in transcription by RNA polymerase II
47. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study
48. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1
49. A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects
50. The 22q11 deletion syndromes
51. Paradox segmentation along inter- and intrasomitic borderlines is followed by dysmorphology of the axial skeleton in the open brain (opb) mouse mutant
52. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription
53. Presenting symptoms and clinical features in 130 patients with the velo-cardiofacial syndrome. The Leuven experience
54. ATP-dependent chromatin-remodeling complexes
55. Mutations of UFD1L are not responsible for the majority of cases of DiGeorge syndrome/velocardiofacial syndrome without deletions within chromosome 22q11
56. The murine homologue of HIRA, a DiGeorge syndrome candidate gene, is expressed in embryonic structures affected in human CATCH22 patients
57. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects